Applying the same idea to treating pancreatic cancer, the present study examined the novel approach of activating K-Ras signaling in MSCs and PBMCs, generating CM, and analyzing the downstream effects of MSC CM on pancreatic cancer cell growth and migration. Here, KRAS is linked to familial pancreatic carcinoma.